Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 3/2010

01.03.2010 | Focus on

PET/CT in head and neck cancer: an update

verfasst von: Roland Hustinx, Giovanni Lucignani

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Excerpt

“The greater risk for most of us lies not in setting our aim too high and falling short; but in setting it too low, and achieving it.”
Michelangelo Buonarroti (1475–1564)
Literatur
1.
Zurück zum Zitat Conway DI, Hashibe M, Boffetta P, INHANCE Consortium, Wunsch-Filho V, Muscat J, et al. Enhancing epidemiologic research on head and neck cancer: INHANCE—The international head and neck cancer epidemiology consortium. Oral Oncol. 2009;45(9):743–6.CrossRefPubMed Conway DI, Hashibe M, Boffetta P, INHANCE Consortium, Wunsch-Filho V, Muscat J, et al. Enhancing epidemiologic research on head and neck cancer: INHANCE—The international head and neck cancer epidemiology consortium. Oral Oncol. 2009;45(9):743–6.CrossRefPubMed
2.
Zurück zum Zitat Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol. 2009. [Epub ahead of print] doi:10.3174/ajnr.A1760. Subramaniam RM, Truong M, Peller P, Sakai O, Mercier G. Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol. 2009. [Epub ahead of print] doi:10.​3174/​ajnr.​A1760.
3.
Zurück zum Zitat Schöder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50 Suppl 1:74S–88S.CrossRefPubMed Schöder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50 Suppl 1:74S–88S.CrossRefPubMed
4.
Zurück zum Zitat Chu HR, Kim JH, Yoon DY, Hwang HS, Rho Y. Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases. Otolaryngol Head Neck Surg. 2009;141(5):633–8.CrossRefPubMed Chu HR, Kim JH, Yoon DY, Hwang HS, Rho Y. Additional diagnostic value of (18)F-FDG PET-CT in detecting retropharyngeal nodal metastases. Otolaryngol Head Neck Surg. 2009;141(5):633–8.CrossRefPubMed
5.
Zurück zum Zitat Sher DJ, Tishler RB, Annino D, Punglia RS. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol. 2009. [Epub ahead of print]. doi:10.1093/annonc/mdp405. Sher DJ, Tishler RB, Annino D, Punglia RS. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol. 2009. [Epub ahead of print]. doi:10.​1093/​annonc/​mdp405.
6.
Zurück zum Zitat Balogova S, Périé S, Kerrou K, Grahek D, Montravers F, Angelard B, et al. Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma. Mol Imaging Biol. 2008;10(6):364–73.CrossRefPubMed Balogova S, Périé S, Kerrou K, Grahek D, Montravers F, Angelard B, et al. Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma. Mol Imaging Biol. 2008;10(6):364–73.CrossRefPubMed
7.
Zurück zum Zitat Hwang HS, Perez DA, Orloff LA. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope. 2009;119(10):1958–65.CrossRefPubMed Hwang HS, Perez DA, Orloff LA. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer. Laryngoscope. 2009;119(10):1958–65.CrossRefPubMed
8.
Zurück zum Zitat Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 2009. [Epub ahead of print]. doi:10.1002/hed.21184. Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 2009. [Epub ahead of print]. doi:10.​1002/​hed.​21184.
9.
Zurück zum Zitat Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, et al. Comparison of whole-body FDG-PET/CT, dedicated high-resolution head and neck FDG-PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med. 2009;50(8):1205–13.CrossRefPubMed Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, et al. Comparison of whole-body FDG-PET/CT, dedicated high-resolution head and neck FDG-PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med. 2009;50(8):1205–13.CrossRefPubMed
10.
Zurück zum Zitat Chung MK, Jeong HS, Park SG, Jang JY, Son YI, Choi JY, et al. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res. 2009;15(18):5861–8.CrossRefPubMed Chung MK, Jeong HS, Park SG, Jang JY, Son YI, Choi JY, et al. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res. 2009;15(18):5861–8.CrossRefPubMed
11.
Zurück zum Zitat Schinagl DA, Hoffmann AL, Vogel WV, van Dalen JA, Verstappen SM, Oyen WJ, et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? Radiother Oncol. 2009;91(1):95–100.CrossRefPubMed Schinagl DA, Hoffmann AL, Vogel WV, van Dalen JA, Verstappen SM, Oyen WJ, et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer? Radiother Oncol. 2009;91(1):95–100.CrossRefPubMed
12.
Zurück zum Zitat Yu H, Caldwell C, Mah K, Mozeg D. Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans Med Imaging. 2009;28(3):374–83.CrossRefPubMed Yu H, Caldwell C, Mah K, Mozeg D. Coregistered FDG PET/CT-based textural characterization of head and neck cancer for radiation treatment planning. IEEE Trans Med Imaging. 2009;28(3):374–83.CrossRefPubMed
13.
Zurück zum Zitat Yu H, Caldwell C, Mah K, Poon I, Balogh J, MacKenzie R, et al. Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys. 2009;75(2):618–25.PubMed Yu H, Caldwell C, Mah K, Poon I, Balogh J, MacKenzie R, et al. Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. Int J Radiat Oncol Biol Phys. 2009;75(2):618–25.PubMed
14.
Zurück zum Zitat Jansen JF, Schöder H, Lee NY, Wang Y, Pfister DG, Fury MG, Stambuk HE, Humm JL, Koutcher JA, Shukla-Dave A. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys. 2009. doi:10.1016/j.ijrobp.2009.07.009. Jansen JF, Schöder H, Lee NY, Wang Y, Pfister DG, Fury MG, Stambuk HE, Humm JL, Koutcher JA, Shukla-Dave A. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys. 2009. doi:10.​1016/​j.​ijrobp.​2009.​07.​009.
15.
Zurück zum Zitat Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009;50(7):1020–7.CrossRefPubMed Dirix P, Vandecaveye V, De Keyzer F, Stroobants S, Hermans R, Nuyts S. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009;50(7):1020–7.CrossRefPubMed
16.
Zurück zum Zitat Rabalais AG, Walvekar R, Nuss D, McWhorter A, Wood C, Fields R, et al. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy. Laryngoscope. 2009;119(6):1120–4.CrossRefPubMed Rabalais AG, Walvekar R, Nuss D, McWhorter A, Wood C, Fields R, et al. Positron emission tomography-computed tomography surveillance for the node-positive neck after chemoradiotherapy. Laryngoscope. 2009;119(6):1120–4.CrossRefPubMed
17.
Zurück zum Zitat Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, et al. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography. Arch Otolaryngol Head Neck Surg. 2009;135(11):1119–25.CrossRefPubMed Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, et al. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography. Arch Otolaryngol Head Neck Surg. 2009;135(11):1119–25.CrossRefPubMed
18.
Zurück zum Zitat Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, et al. Clinical significance of postradiotherapy FDG-PET imaging in management of head-and-neck cancer—a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009;74(1):9–14.PubMed Yao M, Smith RB, Hoffman HT, Funk GF, Lu M, Menda Y, et al. Clinical significance of postradiotherapy FDG-PET imaging in management of head-and-neck cancer—a long-term outcome report. Int J Radiat Oncol Biol Phys. 2009;74(1):9–14.PubMed
19.
Zurück zum Zitat Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope. 2009;119(11):2150–5.CrossRefPubMed Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA. Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer. Laryngoscope. 2009;119(11):2150–5.CrossRefPubMed
20.
Zurück zum Zitat Hoshikawa H, Mitani T, Nishiyama Y, Yamamoto Y, Ohkawa M, Mori N. Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET. Auris Nasus Larynx. 2009;36(2):192–8.CrossRefPubMed Hoshikawa H, Mitani T, Nishiyama Y, Yamamoto Y, Ohkawa M, Mori N. Evaluation of the therapeutic effects and recurrence for head and neck cancer after chemoradiotherapy by FDG-PET. Auris Nasus Larynx. 2009;36(2):192–8.CrossRefPubMed
21.
Zurück zum Zitat Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, et al. Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009;27(15):2509–15.CrossRefPubMed Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, et al. Prospective risk-adjusted [18F]fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009;27(15):2509–15.CrossRefPubMed
22.
Zurück zum Zitat Hentschel M, Appold S, Schreiber A, Abramyuk A, Abolmaali N, Kotzerke J, et al. Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy. Int J Radiat Biol. 2009;85(9):796–804.CrossRefPubMed Hentschel M, Appold S, Schreiber A, Abramyuk A, Abolmaali N, Kotzerke J, et al. Serial FDG-PET on patients with head and neck cancer: implications for radiation therapy. Int J Radiat Biol. 2009;85(9):796–804.CrossRefPubMed
23.
Zurück zum Zitat Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer. 2009;115(19):4586–94.CrossRefPubMed Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, et al. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer. 2009;115(19):4586–94.CrossRefPubMed
24.
Zurück zum Zitat Martin RC, Fulham M, Shannon KF, Hughes C, Gao K, Milross C, et al. Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head Neck. 2009;31(2):244–50.CrossRefPubMed Martin RC, Fulham M, Shannon KF, Hughes C, Gao K, Milross C, et al. Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head Neck. 2009;31(2):244–50.CrossRefPubMed
25.
Zurück zum Zitat Lee N, Nehmeh S, Schöder H, Fury M, Chan K, Ling CC, et al. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;75(1):101–8.PubMed Lee N, Nehmeh S, Schöder H, Fury M, Chan K, Ling CC, et al. Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;75(1):101–8.PubMed
Metadaten
Titel
PET/CT in head and neck cancer: an update
verfasst von
Roland Hustinx
Giovanni Lucignani
Publikationsdatum
01.03.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2010
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-009-1365-9

Weitere Artikel der Ausgabe 3/2010

European Journal of Nuclear Medicine and Molecular Imaging 3/2010 Zur Ausgabe